Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > NDA/ANDA/505

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Jul 02, 2024 3:45pm

48 Views

Post# 36115041

RE:RE:RE:RE:NDA/ANDA/505

Solid1 wrote: The ANDA will be approved for a new therapy, and the NDA has already been mentioned several times, most recently in the last quarterly report

The acronym NDA certainly is mentioned in the last quarterly report, however as I've stated before as well, there is a big difference between a NDA and an 'investigational' NDA. The report refers to the latter.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages